{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:39:00Z","timestamp":1783489140162,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD088638"],"award-info":[{"award-number":["R01HD088638"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.fertnstert.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T17:27:41Z","timestamp":1616174861000},"page":"208-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Duration, recency, and type of hormonal contraceptive use and antim\u00fcllerian hormone levels"],"prefix":"10.1016","volume":"116","author":[{"given":"Lia A.","family":"Bernardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa Steinberg","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Waldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quaker","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes R.","family":"Carnethon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna D.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica E.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.02.007_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Anti-m\u00fcllerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antimullerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti- M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib5","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1210\/jc.2006-1066","article-title":"Estradiol and regulation of anti-M\u00fcllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles\u2019 fluid","volume":"91","author":"Andersen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/humrep\/del421","article-title":"Anti-M\u00fcllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology","volume":"22","author":"La Marca","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib9","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women","volume":"96","author":"Broer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2008-1818","article-title":"Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure","volume":"94","author":"Knauff","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.AOG.0000459864.68372.ec","article-title":"Committee opinion no. 618: ovarian reserve testing","volume":"125","author":"Committee on Gynecologic","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib14","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1210\/jc.2010-0930","article-title":"Serum levels of anti-M\u00fcllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients","volume":"95","author":"Hagen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022024","article-title":"A validated model of serum anti-m\u00fcllerian hormone from conception to menopause","volume":"6","author":"Kelsey","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejogrb.2012.04.013","article-title":"Normal serum anti-M\u00fcllerian hormone levels in the general female population and the relationship with reproductive history","volume":"163","author":"La Marca","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib17","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-m\u00fcllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.fertnstert.2010.08.022","article-title":"Nomogram for the decline in serum antim\u00fcllerian hormone: a population study of 9,601 infertility patients","volume":"95","author":"Nelson","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.fertnstert.2010.10.011","article-title":"Age-specific serum anti-M\u00fcllerian hormone values for 17,120 women presenting to fertility centers within the United States","volume":"95","author":"Seifer","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib20","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1210\/jc.2012-3995","article-title":"Reproductive and lifestyle determinants of anti-M\u00fcllerian hormone in a large population-based study","volume":"98","author":"D\u00f3lleman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.fertnstert.2013.09.015","article-title":"Race\/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race\/ethnic groups of healthy, regularly cycling women","volume":"101","author":"Bleil","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.fertnstert.2016.04.008","article-title":"Novel correlates between antim\u00fcllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old)","volume":"106","author":"Marsh","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib23","first-page":"1","article-title":"Current contraceptive status among women aged 15-44: United States, 2011-2013","volume":"173","author":"Daniels","year":"2014","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib24","first-page":"1","article-title":"Contraceptive methods women have ever used: United States, 1982-2010","volume":"62","author":"Daniels","year":"2013","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13625187.2019.1702158","article-title":"Ovarian reserve markers in women using various hormonal contraceptives","volume":"25","author":"Landersoe","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib26","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/humrep\/dem258","article-title":"Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills","volume":"22","author":"Arbo","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2012.09.001","article-title":"Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception","volume":"25","author":"Bentzen","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/09513590.2010.487595","article-title":"The effect of different hormone therapies on anti-m\u00fcllerian hormone serum levels in anovulatory women of reproductive age","volume":"27","author":"F\u00e1bregues","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2014.05.026","article-title":"Antim\u00fcllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception","volume":"102","author":"Johnson","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2012.11.034","article-title":"Antimullerian hormone levels decrease in women using combined contraception independently of administration route","volume":"99","author":"Kallio","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.fertnstert.2011.12.017","article-title":"The association between circulating levels of antim\u00fcllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women","volume":"97","author":"Kristensen","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib32","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.fertnstert.2011.05.051","article-title":"Serum antim\u00fcllerian hormone in healthy premenopausal women","volume":"95","author":"Shaw","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib33","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/humrep\/deq071","article-title":"Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases","volume":"25","author":"van den Berg","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib34","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/humrep\/dev197","article-title":"Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan","volume":"30","author":"Birch Petersen","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/uog.10114","article-title":"Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-M\u00fcllerian hormone and small antral follicle count using three-dimensional ultrasound","volume":"39","author":"Deb","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.contraception.2010.09.007","article-title":"Serum anti-m\u00fcllerian hormone level is not altered in women using hormonal contraceptives","volume":"83","author":"Li","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-M\u00fcllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2009.10.004","article-title":"Antimullerian hormone and obesity: insights in oral contraceptive users","volume":"81","author":"Steiner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","article-title":"Serum antim\u00fcllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids","volume":"90","author":"Streuli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/jwh.2019.7733","article-title":"Assessment of circulating anti-m\u00fcllerian hormone in women using hormonal contraception: a systematic review","volume":"29","author":"Amer","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.rbmo.2019.10.004","article-title":"Ovarian reserve markers after discontinuing long-term use of combined oral contraceptives","volume":"40","author":"Landersoe","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/jwh.2015.5277","article-title":"A prospective, ultrasound-based study to evaluate risk factors for uterine fibroid incidence and growth: methods and results of recruitment","volume":"24","author":"Baird","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib44","doi-asserted-by":"crossref","first-page":"758.e1","DOI":"10.1016\/j.ajog.2016.07.012","article-title":"Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women","volume":"215","author":"Hawkins Bressler","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(78)90617-7","article-title":"Smoking and industrial pollution, and their effects on menopause and ovarian cancer","volume":"1","author":"Mattison","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/gme.0b013e3181c7deba","article-title":"The impact of smoking on antim\u00fcllerian hormone levels in women aged 38 to 50 years","volume":"17","author":"Plante","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.fertnstert.2005.01.115","article-title":"Per-follicle measurements indicate that anti-m\u00fcllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status","volume":"84","author":"Fanchin","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/09513590.2015.1121981","article-title":"Effect of long-term using of hormonal contraception on anti-M\u00fcllerian hormone secretion","volume":"32","author":"Kucera","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib49","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/aje\/153.9.865","article-title":"Factors associated with age at natural menopause in a multiethnic sample of midlife women","volume":"153","author":"Gold","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib50","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/aje\/kwn046","article-title":"Predictors of the timing of natural menopause in the Multiethnic Cohort Study","volume":"167","author":"Henderson","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib51","doi-asserted-by":"crossref","first-page":"353.e1","DOI":"10.1016\/j.ajog.2011.05.014","article-title":"Racial and regional differences in age at menopause in the United States: findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"205","author":"McKnight","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib52","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.fertnstert.2008.08.110","article-title":"Variations in serum mullerian inhibiting substance between white, black, and Hispanic women","volume":"92","author":"Seifer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib53","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ije\/27.6.1033","article-title":"Oral contraceptive use: interview data versus pharmacy records","volume":"27","author":"Norell","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.annepidem.2014.10.009","article-title":"A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women","volume":"25","author":"Spangler","year":"2015","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/oxfordjournals.aje.a116907","article-title":"Comparison of recalled and validated oral contraceptive histories","volume":"138","author":"Nischan","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2021.02.007_bib56","series-title":"Current contraceptive status among women aged 15\u201344: United States, 2011\u20132013. NCHS data brief, no 173","author":"Daniels","year":"2014"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:31:01Z","timestamp":1758011461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028221001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0015028221001266"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.007","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration, recency, and type of hormonal contraceptive use and antim\u00fcllerian hormone levels","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}